Related references
Note: Only part of the references are listed.Next generation sequencing as second-tier test in high-throughput newborn screening for nephropathic cystinosis
Tobias Fleige et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases
Li Ou et al.
GENE THERAPY (2020)
Genome Editing for Mucopolysaccharidoses
Edina Poletto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Setup and Validation of a Targeted Next-Generation Sequencing Approach for the Diagnosis of Lysosomal Storage Disorders
Alessandra Zanetti et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
High incidence of Gaucher disease in northeast Italy: Results from lysosomal newborn screening
Alberto Burlina et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Newborn screening for MPS I: The clinical benefit
Alberto Burlina et al.
MOLECULAR GENETICS AND METABOLISM (2020)
The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease
Jorge A. Bevilacqua et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease
May Thandar Aung-Htut et al.
SCIENTIFIC REPORTS (2020)
Novel GAA Variants and Mosaicism in Pompe Disease Identified by Extended Analyses of Patients with an Incomplete DNA Diagnosis
Stijn L. M. in't Groen et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
microRNAs as biomarkers in Pompe disease
Antonietta Tarallo et al.
GENETICS IN MEDICINE (2019)
Development of a fast LC-MS/MS protocol for combined measurement of six LSDs on dried blood spot in a newborn screening program
Emanuela Scolamiero et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2019)
Maternal germline mosaicism in Fabry disease
Luigi Pianese et al.
NEUROLOGICAL SCIENCES (2019)
Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study
Giulia Polo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
An update on gene therapy for lysosomal storage disorders
Murtaza S. Nagree et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Sensitivity, advantages, limitations, and clinical utility of targeted next-generation sequencing panels for the diagnosis of selected lysosomal storage disorders
Diana Rojas Malaga et al.
GENETICS AND MOLECULAR BIOLOGY (2019)
Lysosomal diseases: Overview on current diagnosis and treatment
Fabiano de Oliveira Poswar et al.
GENETICS AND MOLECULAR BIOLOGY (2019)
Identification of serum microRNAs as potential biomarkers in Pompe disease
Ana Carrasco-Rozas et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Identification of Five Novel Mutations Causing Rare Lysosomal Storage Diseases
Chenxi Yang et al.
MEDICAL SCIENCE MONITOR (2019)
LC-MS/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization
Giulia Forni et al.
CLINICA CHIMICA ACTA (2019)
Lysosomal storage disorders - challenges, concepts and avenues for therapy: beyond rare diseases
Andre R. A. Marques et al.
JOURNAL OF CELL SCIENCE (2019)
Clinical implementation of gene panel testing for lysosomal storage diseases
Alexander Gheldof et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2019)
Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates
Hyunjoo Lee et al.
YONSEI MEDICAL JOURNAL (2019)
Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
Michael H. Gelb et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2019)
Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy
Alberto B. Burlina et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2019)
Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service
Julia C. van Campen et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2019)
Identification of serum microRNAs as potential biomarkers in Pompe disease
Ana Carrasco-Rozas et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy
Alberto B. Burlina et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
Genotype, phenotype and in silico pathogenicity analysis of HEXB mutations: Panel based sequencing for differential diagnosis of gangliosidosis
Nejat Mahndieh et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Newborn Screening for Lysosomal Storage Disorders
Sharon Anderson
JOURNAL OF PEDIATRIC HEALTH CARE (2018)
Alpha galactosidase A activity in Parkinson's disease
R. N. Alcalay et al.
NEUROBIOLOGY OF DISEASE (2018)
Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis
Duan Li et al.
PRENATAL DIAGNOSIS (2018)
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
Giuseppe Cammarata et al.
Oncotarget (2018)
Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders
Andrea Dardis et al.
GENES (2018)
Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies
Josephine Johnston et al.
HASTINGS CENTER REPORT (2018)
Exploring genetic modifiers of Gaucher disease: The next horizon
Brad A. Davidson et al.
HUMAN MUTATION (2018)
Lysosomal storage diseases
Frances M. Platt et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases
Mindy Li
PEDIATRIC ANNALS (2018)
Newborn Screening for Lysosomal Storage Diseases: Methodologies, Screen Positive Rates, Normalization of Datasets, Second-Tier Tests, and Post-Analysis Tools
Michael H. Gelb
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2018)
Current State of the Art of Newborn Screening for Lysosomal Storage Disorders
David S. Millington et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2018)
Treatment strategies for lysosomal storage disorders
Michael Beck
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A. Hughes et al.
JOURNAL OF MEDICAL GENETICS (2017)
Using whole-exome sequencing to investigate the genetic bases of lysosomal storage diseases of unknown etiology
Nan Wang et al.
HUMAN MUTATION (2017)
Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease
Mari Mori et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid α-Glucosidase in Pompe Patients Co-administered with Alglucosidase α
Priya Kishnani et al.
MOLECULAR THERAPY (2017)
Newborn Sequencing in Genomic Medicine and Public Health
Jonathan S. Berg et al.
PEDIATRICS (2017)
Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises
Fedah E. Mohamed et al.
FRONTIERS IN PHARMACOLOGY (2017)
Antisense Oligonucleotides Promote Exon Inclusion and Correct the Common c.-32-13T>G GAA Splicing Variant in Pompe Disease
Erik van der Wal et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Next generation deep sequencing corrects diagnostic pitfalls of traditional molecular approach in a patient with prenatal onset of Pompe disease
Anne Chun-Hui Tsai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases
L. Kuchar et al.
ANALYTICAL BIOCHEMISTRY (2017)
Metabolic progression to clinical phenotype in classic Fabry disease
Marco Spada et al.
ITALIAN JOURNAL OF PEDIATRICS (2017)
Newborn testing and screening by whole-genome sequencing
Stephen F. Kingsmore
GENETICS IN MEDICINE (2016)
Carrier screening in the era of expanding genetic technology
Aishwarya Arjunan et al.
GENETICS IN MEDICINE (2016)
A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders
Zornitza Stark et al.
GENETICS IN MEDICINE (2016)
LYSOSOMAL STORAGE DISORDERS 4 BIG QUESTIONS
Michael Eisenstein
NATURE (2016)
Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing
Sebastien Levesque et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Prenatal diagnosis of Gaucher disease using next-generation sequencing
Shinichiro Yoshida et al.
PEDIATRICS INTERNATIONAL (2016)
Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism
Delia Yubero et al.
PLOS ONE (2016)
Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations
Lorenzo Ferri et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Expanded Newborn Screening: A Chess Board Motif in Public Health
Agata Polizzi et al.
JOURNAL OF PEDIATRIC BIOCHEMISTRY (2016)
Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders
Maria Francisca Coutinho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Lysosomal Storage Diseases: From Pathophysiology to Therapy
Giancarlo Parenti et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway
Giuseppina Di Fruscio et al.
AUTOPHAGY (2015)
Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening
Sandra D. K. Kingma et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Newborn Screening for Lysosomal Storage Diseases
Michael H. Gelb et al.
CLINICAL CHEMISTRY (2015)
Genome Editing: Potential Treatment for Lysosomal Storage Diseases
Talita Giacomet de Carvalho et al.
CURRENT STEM CELL REPORTS (2015)
Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations
Liliana Matos et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
New strategies for the treatment of lysosomal storage diseases (Review)
Giancarlo Parenti et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation
Yin-Hsiu Chien et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots
Britt Johnson et al.
ANNALS OF LABORATORY MEDICINE (2013)
Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening
Jodi D. Hoffman et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2013)
First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene
Silvia Paciotti et al.
CLINICA CHIMICA ACTA (2012)
Enzyme replacement therapy for lysosomal storage diseases
Robin H. Lachmann
CURRENT OPINION IN PEDIATRICS (2011)
Lysosomal storage diseases: Diagnostic confirmation and management of presymptomatic individuals
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2011)
Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies
Johannes M. F. G. Aerts et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Antisense Oligonucleotide Treatment for a Pseudoexon-Generating Mutation in the NPC1 Gene Causing Niemann-Pick Type C
Laura Rodriguez-Pascau et al.
HUMAN MUTATION (2009)
Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years
Anne Andermann et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Gene therapy for lysosomal storage diseases
Mark S. Sands et al.
MOLECULAR THERAPY (2006)
Share Paper
